Irritable Bowel Syndrome Trial, Recruiting NCT07584278 Sponsor: Sahlgrenska University Hospital Condition: Irritable Bowel Syndrome
Back to Irritable Bowel Syndrome

Irritable Bowel Syndrome Trial, Recruiting

NCT07584278
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with Irritable Bowel Syndrome (IBS) using a specific set of diagnostic guidelines called ROME V criteria
  • Your IBS symptoms are rated at a certain level of severity (a score of 75 or above on a standard IBS symptom scale — confirm with trial site)
  • You are 18 years of age or older
  • Your Body Mass Index (BMI) falls between 18.5 and 35 (a measure of weight relative to height)
  • You are able to read and understand the study information and are willing to follow the study's rules and schedule
  • You are able to give your formal agreement to take part in the study
  • You are able to complete questionnaires written in Swedish

Who may not be able to join:

  • You have a history of any gut conditions (such as coeliac disease), or heart, liver, neurological, or current mental health conditions, diabetes, or have had abdominal surgery that affects how your bowel works (though some surgeries like gallbladder removal, appendix removal, or caesarean section are not excluded)
  • You have used opioid-based pain medications in the month before the study or plan to use them during the study
  • You have taken probiotic supplements in the 14 days before joining or plan to take them during the study (eating foods that naturally contain probiotics is allowed)
  • You have taken antibiotics in the 3 months before the study or plan to during the study
  • You have recently started any new medications that affect your gut or digestive symptoms, or have started a new diet or psychological therapy to treat your IBS within the last month
  • You have taken part in any other medical research study in the last month
  • Your lab test results show certain abnormal levels, particularly relating to a stool marker called calprotectin (confirm with trial site for exact thresholds)
  • You are currently pregnant, planning to become pregnant during the study, or are breastfeeding
  • You drink more than 14 units of alcohol per week
  • You have used recreational drugs in the month before the study or plan to during the study
  • You have used medications that mainly affect bowel function, stool consistency, or how quickly food moves through your gut in the 2 weeks before the study or during the 12-week study period

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Magnus Simren, MD PHD, Göteborg University

Phone: 0046313428107

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Sahlgrenska University Hospital
Registry
ClinicalTrials.gov
Start date
28 April 2026
Est. completion
1 April 2031

Where this trial is recruiting

🇸🇪 Sweden

Primary endpoints

IBS symptom severity (IBS-Symptom-Severity-Score)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov